Rchr
J-GLOBAL ID:201701020155894590   Update date: Apr. 12, 2024

Ninomiya Masashi

ニノミヤ マサシ | Ninomiya Masashi
Affiliation and department:
Job title: Assistant Professor
Homepage URL  (1): http://www.health.ihe.tohoku.ac.jp/
Research field  (1): Other
Research theme for competitive and other funds  (4):
  • 2023 - 2026 ミトコンドリアを介する自然免疫応答を標的としたB型肝炎ウイルスの制御と肝発癌抑制
  • 2020 - 2023 肝細胞脂肪変性における遊離アミノ酸の細胞内ストレス応答機構に与えるインパクト
  • 2019 - 2022 Mechanistic analysis of hepatitis B virus infection focusing on vesicle trafficking system and its clinical application
  • 2011 - 2012 The possibility of unknown viral infection with primary biliary cirrhosis and the disease association with anellovirus infection.
Papers (143):
  • Jun Inoue, Takehiro Akahane, Tomoo Kobayashi, Osamu Kimura, Kosuke Sato, Masashi Ninomiya, Tomoaki Iwata, Satoshi Takai, Norihiro Kisara, Toshihiro Sato, et al. Usefulness of the Fibrosis-4 index and alanine aminotransferase at 1 year of nucleos(t)ide analog treatment for prediction of hepatocellular carcinoma in chronic hepatitis B patients. Hepatology research : the official journal of the Japan Society of Hepatology. 2024. 54. 2. 131-141
  • Masashi Ninomiya, Mio Tsuruoka, Jun Inoue, Atsushi Hiraoka, Tomoaki Iwata, Akitoshi Sano, Kosuke Sato, Masazumi Onuki, Satoko Sawahashi, Hidekatsu Kuroda, et al. A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC intermediate stage. Scientific reports. 2023. 13. 1. 20739-20739
  • Kosuke Sato, Jun Inoue, Masashi Ninomiya, Tomoaki Iwata, Akitoshi Sano, Mio Tsuruoka, Masazumi Onuki, Satoko Sawahashi, Keishi Ouchi, Atsushi Masamune. Effectiveness of tacrolimus in a case of immune checkpoint inhibitor-induced hepatotoxicity that was refractory to steroids and mycophenolate mofetil. Clinical journal of gastroenterology. 2023
  • 鶴岡 未央, 二宮 匡史, 正宗 淳. 肝疾患における有害事象をめぐる諸問題(薬物性肝障害を含めて) 当院のirAE肝障害患者の現状とステロイド及びMMF抵抗性症例に対するタクロリムスの使用経験. 肝臓. 2023. 64. Suppl.1. A214-A214
  • 佐野 晃俊, 井上 淳, 嘉数 英二, 二宮 匡史, 岩田 朋晃, 鶴岡 未央, 佐藤 公亮, 小貫 真純, 澤橋 里子, 大内 啓志, et al. 肝硬変の成因と病態の推移 当院の肝癌治療患者における肝硬変の成因推移. 肝臓. 2023. 64. Suppl.1. A245-A245
more...
MISC (120):
Professional career (1):
  • Ph.D (Tohoku University)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page